Cargando…
The obesity paradox and hypoglycemia in critically ill patients
BACKGROUND: A high body mass index (BMI) has been associated with decreased mortality in critically ill patients. This association may, in part, relate to the impact of BMI on glycemia. We aimed to study the relationship between BMI, glycemia and hospital mortality. METHODS: We included all patients...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559391/ https://www.ncbi.nlm.nih.gov/pubmed/34724956 http://dx.doi.org/10.1186/s13054-021-03795-z |
_version_ | 1784592750626209792 |
---|---|
author | Plečko, Drago Bennett, Nicolas Mårtensson, Johan Bellomo, Rinaldo |
author_facet | Plečko, Drago Bennett, Nicolas Mårtensson, Johan Bellomo, Rinaldo |
author_sort | Plečko, Drago |
collection | PubMed |
description | BACKGROUND: A high body mass index (BMI) has been associated with decreased mortality in critically ill patients. This association may, in part, relate to the impact of BMI on glycemia. We aimed to study the relationship between BMI, glycemia and hospital mortality. METHODS: We included all patients with a recorded BMI from four large international clinical databases (n = 259,177). We investigated the unadjusted association of BMI with average glucose levels, mortality and hypoglycemia rate. We applied multivariate analysis to investigate the impact of BMI on hypoglycemia rate, after adjusting for glycemia-relevant treatments (insulin, dextrose, corticosteroids, enteral and parenteral nutrition) and key physiological parameters (previous blood glucose level, blood lactate, shock state, SOFA score). RESULTS: We analyzed 5,544,366 glucose measurements. On unadjusted analysis, increasing BMI was associated with increasing glucose levels (average increase of 5 and 10 mg/dL for the 25–30, 30–35 kg/m(2) BMI groups compared to normal BMI (18.5–25 kg/m(2)) patients). Despite greater hyperglycemia, increasing BMI was associated with lower hospital mortality (average decrease of 2% and 3.25% for the 25–30, 30–35 kg/m(2) groups compared to normal BMI patients) and lower hypoglycemia rate (average decrease of 2.5% and 3.5% for the 25–30, 30–35 kg/m(2) groups compared to normal BMI patients). Increasing BMI was significantly independently associated with reduced hypoglycemia rate, with odds ratio (OR) 0.72 and 0.65, respectively (95% CIs 0.67–0.77 and 0.60–0.71, both p < 0.001) when compared with normal BMI. Low BMI patients showed greater hypoglycemia rate, with OR 1.6 (CI 1.43–1.79, p < 0.001). The association of high BMI and decreased mortality did not apply to diabetic patients. Although diabetic patients had higher rates of hypoglycemia overall and higher glucose variability (p < 0.001), they also had a reduced risk of hypoglycemia with higher BMI levels (p < 0.001). CONCLUSIONS: Increasing BMI is independently associated with decreased risk of hypoglycemia. It is also associated with increasing hyperglycemia and yet with lower mortality. Lower risk of hypoglycemia might contribute to decreased mortality and might partly explain the obesity paradox. These associations, however, were markedly modified by the presence of diabetes. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03795-z. |
format | Online Article Text |
id | pubmed-8559391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85593912021-11-03 The obesity paradox and hypoglycemia in critically ill patients Plečko, Drago Bennett, Nicolas Mårtensson, Johan Bellomo, Rinaldo Crit Care Research BACKGROUND: A high body mass index (BMI) has been associated with decreased mortality in critically ill patients. This association may, in part, relate to the impact of BMI on glycemia. We aimed to study the relationship between BMI, glycemia and hospital mortality. METHODS: We included all patients with a recorded BMI from four large international clinical databases (n = 259,177). We investigated the unadjusted association of BMI with average glucose levels, mortality and hypoglycemia rate. We applied multivariate analysis to investigate the impact of BMI on hypoglycemia rate, after adjusting for glycemia-relevant treatments (insulin, dextrose, corticosteroids, enteral and parenteral nutrition) and key physiological parameters (previous blood glucose level, blood lactate, shock state, SOFA score). RESULTS: We analyzed 5,544,366 glucose measurements. On unadjusted analysis, increasing BMI was associated with increasing glucose levels (average increase of 5 and 10 mg/dL for the 25–30, 30–35 kg/m(2) BMI groups compared to normal BMI (18.5–25 kg/m(2)) patients). Despite greater hyperglycemia, increasing BMI was associated with lower hospital mortality (average decrease of 2% and 3.25% for the 25–30, 30–35 kg/m(2) groups compared to normal BMI patients) and lower hypoglycemia rate (average decrease of 2.5% and 3.5% for the 25–30, 30–35 kg/m(2) groups compared to normal BMI patients). Increasing BMI was significantly independently associated with reduced hypoglycemia rate, with odds ratio (OR) 0.72 and 0.65, respectively (95% CIs 0.67–0.77 and 0.60–0.71, both p < 0.001) when compared with normal BMI. Low BMI patients showed greater hypoglycemia rate, with OR 1.6 (CI 1.43–1.79, p < 0.001). The association of high BMI and decreased mortality did not apply to diabetic patients. Although diabetic patients had higher rates of hypoglycemia overall and higher glucose variability (p < 0.001), they also had a reduced risk of hypoglycemia with higher BMI levels (p < 0.001). CONCLUSIONS: Increasing BMI is independently associated with decreased risk of hypoglycemia. It is also associated with increasing hyperglycemia and yet with lower mortality. Lower risk of hypoglycemia might contribute to decreased mortality and might partly explain the obesity paradox. These associations, however, were markedly modified by the presence of diabetes. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03795-z. BioMed Central 2021-11-01 /pmc/articles/PMC8559391/ /pubmed/34724956 http://dx.doi.org/10.1186/s13054-021-03795-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Plečko, Drago Bennett, Nicolas Mårtensson, Johan Bellomo, Rinaldo The obesity paradox and hypoglycemia in critically ill patients |
title | The obesity paradox and hypoglycemia in critically ill patients |
title_full | The obesity paradox and hypoglycemia in critically ill patients |
title_fullStr | The obesity paradox and hypoglycemia in critically ill patients |
title_full_unstemmed | The obesity paradox and hypoglycemia in critically ill patients |
title_short | The obesity paradox and hypoglycemia in critically ill patients |
title_sort | obesity paradox and hypoglycemia in critically ill patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559391/ https://www.ncbi.nlm.nih.gov/pubmed/34724956 http://dx.doi.org/10.1186/s13054-021-03795-z |
work_keys_str_mv | AT pleckodrago theobesityparadoxandhypoglycemiaincriticallyillpatients AT bennettnicolas theobesityparadoxandhypoglycemiaincriticallyillpatients AT martenssonjohan theobesityparadoxandhypoglycemiaincriticallyillpatients AT bellomorinaldo theobesityparadoxandhypoglycemiaincriticallyillpatients AT pleckodrago obesityparadoxandhypoglycemiaincriticallyillpatients AT bennettnicolas obesityparadoxandhypoglycemiaincriticallyillpatients AT martenssonjohan obesityparadoxandhypoglycemiaincriticallyillpatients AT bellomorinaldo obesityparadoxandhypoglycemiaincriticallyillpatients |